Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 767 of 6351
-
New drug duo aims to stop bladder cancer from coming back
Disease control Recruiting nowThis study aims to evaluate the efficacy and safety of intravenous administration of vedacitinib combined with intravesical instillation of mitomycin in treating patients with high-risk NMIBC with HER2 expression. The goal is to provide a new treatment option for NMIBC patients, …
Phase 2 • Sponsor: Shanxi Province Cancer Hospital • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
New drug targets rare protein disease in early trial
Disease control Recruiting nowImmunoglobulin light chain (AL) amyloidosis is the most common form of systemic amyloidosis. AL amyloidosis has many root causes and is characterized by the overproduction of AL that are secreted by clonal bone marrow plasma cells. This is a study to determine adverse events and …
Phase 1/2 • Sponsor: AbbVie • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
A blood test for sleep apnea? MicroRNAs may hold the key
Diagnosis Recruiting nowAlthough obstructive sleep apnea (OSA) is a common disorder, there are no blood biomarkers for identification and management of these patients. This project will study microRNAs in order to develop and validate blood biomarkers that are specific to OSA, useful for identification …
Sponsor: University of Pennsylvania • Aim: Diagnosis
Last updated Aug 05, 2026 00:00 UTC
-
Can a Three-Pronged therapy reboot the brain after injury?
Disease control Recruiting nowThis study will conduct a single-center clinical trial to explore the initial therapeutic effect of ginkgo biloba dropping pills, huperzine A injection and median nerve electrical stimulation in patients with cognitive impairment.
Phase 4 • Sponsor: Wanbangde Pharmaceutical Group Co., LTD • Aim: Disease control
Last updated Aug 19, 2026 00:00 UTC
-
Texting teens to tame risky drinking and weed use?
Disease control CompletedThe goal of this treatment development project is to develop an adaptive ecological momentary intervention (a-EMI) for young adults using marijuana and alcohol that is grounded in self-regulation and social cognitive theories. To determine the most efficacious intervention strate…
Sponsor: Kaiser Permanente • Aim: Disease control
Last updated Aug 23, 2026 00:00 UTC
-
Can fish oils calm endometriosis inflammation?
Disease control CompletedEndometriosis is a chronic inflammatory gynecological disease that may be associated with pelvic pain, painful menstruation, reduced quality of life, impaired daily functioning, and changes in nutritional and metabolic health. Diet, particularly the type and amount of dietary fat…
Sponsor: Angelika Bogusz • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
New scan could help doctors spot hidden prostate cancer spread
Diagnosis OngoingThis is a prospective, open-label Phase 3 study to evaluate copper Cu 64 PSMA I\&T injection for PET/CT imaging in patients with newly diagnosed unfavorable intermediate high-risk, high-risk or very high-risk prostate cancer.
Phase 3 • Sponsor: Curium US LLC • Aim: Diagnosis
Last updated Aug 16, 2026 00:00 UTC
-
Can a custom healing cap preserve gum and bone after tooth extraction?
Disease control Recruiting nowImmediate implant placement into a fresh extraction socket shortens overall treatment time and reduces the number of surgical procedures, but the fit between the implant and the socket walls, and the resulting soft-tissue contour, differ substantially between socket types. This s…
Sponsor: Plovdiv Medical University • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
Virus therapy takes on cervical and endometrial cancer
Disease control Recruiting nowRecombinant oncolytic adenovirus injection (KD01)is an oncolytic vius product. Its main component is a conditionally replicativerecombinant human type 5 adenovirus, where part of the E3 region has been replaced with the gene encoding the tBid apoptoticprotein.AK104 is a humanized…
Phase 1 • Sponsor: Tongji Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
AI watches dye flow to predict cancer spread in thyroid surgery
Diagnosis CompletedThe goal of this observational study is to learn if a computer program (deep learning) can accurately predict lymph node spread in adults with papillary thyroid cancer who have no signs of lymph node involvement before surgery (called cN0). The main questions it aims to answer ar…
Sponsor: First Affiliated Hospital of Chongqing Medical University • Aim: Diagnosis
Last updated Jun 27, 2026 09:02 UTC
-
Could a vaccine combo free people with HIV from daily pills?
Disease control PausedThe purpose of this study is to evaluate the safety, tolerability, and efficacy of therapeutic vaccination with chimpanzee adenovirus ChAdOx1- and poxvirus modified vaccinia Ankara (MVA)-vectored conserved mosaic T-cell vaccines in a sequential regimen with the toll-like receptor…
Phase 1/2 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
Smartwatch could spot nerve damage before it starts
Knowledge-focused CancelledThis is a single center prospective observational cohort study that aims to: * examine and identify possible risk and susceptibility factors for the incidence and progression of chemotherapy-induced polyneuropathy (CIPN) in female patients primarily operated for early non-metast…
Sponsor: Theodoros Foukakis • Aim: Knowledge-focused
Last updated Aug 16, 2026 00:00 UTC
-
Can a Self-Care program ease Post-Cancer swelling in the head and neck?
Symptom relief Recruiting nowThe goal of this study is to evaluate the effectiveness of a standardized lymphedema and fibrosis self-management program (LEF-SMP) to improve LEF self-management and reduce LEF-associated symptom burden, functional deficits, and improve quality of life in head and neck cancer (H…
Sponsor: Abramson Cancer Center at Penn Medicine • Aim: Symptom relief
Last updated Sep 06, 2026 00:00 UTC
-
Could a Two-Drug punch protect kidneys in High-Risk patients?
Disease control OngoingThe purpose of this study is to measure the efficacy and safety of baxdrostat/dapagliflozin in participants ≥ 18 years of age with CKD and HTN. This study consists of a screening, a 4-week dapagliflozin run-in period for participants untreated with SGLT2i at baseline; a 24-month…
Phase 3 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Jun 28, 2026 00:00 UTC
-
New drug aims to slow kidney disease in IgA nephropathy patients
Disease control OngoingThe primary objective of this study to evaluate efficacy of ravulizumab compared with placebo on proteinuria reduction and change in eGFR in adult participants with IgAN who are at risk of disease progression.
Phase 3 • Sponsor: Alexion Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
New dengue vaccine trial shows promise for india
Vaccine CompletedThe main aims of the study are to learn about side effects and a participant's immune response to Takeda's Dengue Vaccine when given twice within 3 months. Participants will receive 2 doses of their randomized treatment (vaccine or placebo). Children, teenagers and adults will r…
Phase 3 • Sponsor: Takeda • Aim: Vaccine
Last updated Jun 27, 2026 13:00 UTC
-
New hope against a deadly parasite: LXE408 trial shows promise
Disease control CompletedThis is a randomized, open-label, phase II, single-centre study, with one LXE408 regimen and one calibrator arm with the standard of care SSG combined with PM, to be conducted in male and female adult (≥18 years and \<45 years) patients with confirmed primary visceral leishmanias…
Phase 2 • Sponsor: Drugs for Neglected Diseases • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
Could a thyroid hormone boost heart transplant success?
Disease control Recruiting nowThis will be a prospective, randomized study performed at a single tertiary referral academic medical center (University of California San Francisco, CA), evaluating the survival benefits of levothyroxine compared with no levothyroxine for patients who have undergone heart transp…
Phase 1 • Sponsor: University of California, San Francisco • Aim: Disease control
Last updated Aug 15, 2026 00:00 UTC
-
New nasal spray could tame stage fright in social anxiety
Symptom relief OngoingThis U.S. Phase 3 clinical trial is designed to evaluate the efficacy, safety, and tolerability of the acute intranasal (i.n.) administration of Fasedienol Nasal Spray (fasedienol) (3.2 µg) to relieve symptoms of acute anxiety in adult subjects ages 18 through 65 with Social Anxi…
Phase 3 • Sponsor: VistaGen Therapeutics, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 08:00 UTC
-
New combo therapy aims to stop bladder cancer return after surgery
Disease control OngoingResearchers are looking for new ways to treat people with high-risk muscle-invasive urothelial carcinoma (MIUC). Urothelial carcinoma is a type of bladder cancer that begins in cells that line the inside of the bladder and other parts of the urinary tract, such as part of the kid…
Phase 1/2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC